Vistance Networks (VISN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Agreement for the sale of the Connectivity and Cable Solutions (CCS) segment for $10.5 billion in cash, subject to adjustments, to Amphenol Corporation, with closing expected in the first half of 2026.
Transaction subject to regulatory approvals, antitrust clearance, and stockholder approval; special stockholder meeting and proxy statement to be filed.
Termination rights include a 12-month outside date, extendable for regulatory delays, and reciprocal $367.5 million termination fees under certain conditions.
Ancillary agreements include an Intellectual Property Matters Agreement and Transition Services Agreement for post-closing support.
Forward-looking statements highlight risks related to transaction completion, regulatory approvals, and business impacts.
Voting matters and shareholder proposals
Stockholder approval is a key closing condition; a special meeting will be called and a proxy statement distributed.
Certain directors, officers, and major shareholders have entered into voting agreements to support the transaction.
Termination fee payable if the company accepts a superior proposal and terminates the agreement.
Board of directors and corporate governance
Board unanimously approved the transaction and recommends stockholders vote in favor.
Board retains the right to consider superior proposals and change recommendation under fiduciary duties.
Latest events from Vistance Networks
- Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Proxy outlines director elections, executive pay, auditor ratification, and major ESG progress.VISN
Proxy filing23 Mar 2026 - Core adjusted EBITDA up 176% in 2025; $10/share special distribution planned.VISN
Q4 202526 Feb 2026 - Adjusted EBITDA up nearly 20% as CCS growth offsets declines; $2.1B OWN/DAS sale to aid liquidity.VISN
Q2 20242 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Core adjusted EBITDA up 159% on 23.5% sales growth; 2025 guidance reaffirmed.VISN
Q1 202524 Dec 2025 - Q4 core sales jumped 27% and margins rose, with 2025 EBITDA guidance at $1.00–$1.05B.VISN
Q4 202421 Dec 2025 - Definitive agreement to sell CCS segment to Amphenol, pending shareholder approval and regulatory review.VISN
Proxy Filing2 Dec 2025 - CCS business sale unlocks equity, enables debt repayment, and sets up a major shareholder dividend.VISN
Proxy Filing1 Dec 2025